Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - OTHER LIABILITIES
Other Liabilities REGN - Regeneron Pharmaceuticals, Inc.
1.76 B
LAST VALUE
65.95%
2 YEAR CAGR
34.76%
5 YEAR CAGR
23.26%
10 YEAR CAGR